Relevance of lower airway bacterial colonization, airway inflammation, and pulmonary function in the stable stage of chronic obstructive pulmonary disease

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 29, Issue 12, 2010, Pages 1487-1493

  Zhang, M ^a   Li, Q ^a   Zhang, X Y ^a   Ding, X ^a   Zhu, D ^a   Zhou, X ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIUM IDENTIFICATION; BLOOD GAS ANALYSIS; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HAEMOPHILUS INFLUENZAE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INFLAMMATION; LOWER RESPIRATORY TRACT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SMOKING; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SUPERNATANT;

AGED; BACTERIAL LOAD; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SPUTUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 78651333573     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-010-1027-7     Document Type: Article

References (26)

1. The Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of COPD: 2003. NHLBI/WHO (GOLD) Workshop Report, NIH publication (2003). United States Department of Health and Human Services
2. SG Adams J Melo M Luther, et al. 2000 Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD Chest 117 1345 1352 1:STN:280:DC%2BD3c3mvF2iug%3D%3D 10.1378/chest.117.5.1345 10807821
3. KF Chung 2005 Inflammatory mediators in chronic obstructive pulmonary disease Curr Drug Targets Inflamm Allergy 4 619 625 1:CAS:528:DC%2BD2MXht1GrtbjN 10.2174/156801005774912806 17305518 (Pubitemid 41722372)
4. AD Lopez K Shibuya C Rao, et al. 2006 Chronic obstructive pulmonary disease: current burden and future projections Eur Respir J 27 397 412 1:STN:280:DC%2BD28%2Fmslensw%3D%3D 10.1183/09031936.06.00025805 16452599 (Pubitemid 43180921)
5. KF Chung IM Adcock 2008 Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction Eur Respir J 31 1334 1356 1:CAS:528:DC%2BD1cXosVWisL8%3D 10.1183/09031936.00018908 18515558
6. NR Anthonisen JE Connett RP Murray 2002 Smoking and lung function of Lung Health Study participants after 11 years Am J Respir Crit Care Med 166 675 679 10.1164/rccm.2112096 12204864 (Pubitemid 34971849)
7. SD Aaron JB Angel M Lunau, et al. 2001 Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease Am J Respir Crit Care Med 163 349 355 1:STN:280:DC%2BD3M7ot1Ohuw%3D%3D 11179105
8. S Sethi TF Murphy 2001 Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review Clin Microbiol Rev 14 336 363 1:CAS:528:DC%2BD3MXjtlKhtrc%3D 10.1128/CMR.14.2.336-363.2001 11292642 (Pubitemid 32294674)
9. PJ Barnes 2004 Small airways in COPD N Engl J Med 350 2635 2637 1:CAS:528:DC%2BD2cXltFGgtbg%3D 10.1056/NEJMp048102 15215476 (Pubitemid 38787995)
10. D Banerjee OA Khair D Honeybourne 2004 Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD Eur Respir J 23 685 691 1:STN:280:DC%2BD2czhsVGksA%3D%3D 10.1183/09031936.04.00056804 15176680 (Pubitemid 38618136)
11. IS Patel TAR Seemungal M Wilks, et al. 2002 Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations Thorax 57 759 764 1:STN:280:DC%2BD38vktlSnsA%3D%3D 10.1136/thorax.57.9.759 12200518 (Pubitemid 34984972)
12. 1 decline in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 167 1090 1095 10.1164/rccm.200210-1179OC 12684248 (Pubitemid 36459654)
13. N Soler S Ewig A Torres, et al. 1999 Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease Eur Respir J 14 1015 1022 1:STN:280:DC%2BD3c%2FmtFOqtQ%3D%3D 10.1183/09031936.99.14510159 10596683
14. E Monsó A Rosell G Bonet, et al. 1999 Risk factors for lower airway bacterial colonization in chronic bronchitis Eur Respir J 13 338 342 10.1034/j.1399-3003.1999.13b20.x 10065678 (Pubitemid 29086830)
15. C Sohy C Pilette MS Niederman, et al. 2002 Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Eur Respir J 19 966 975 1:STN:280:DC%2BD383ptVClsQ%3D%3D 10.1183/09031936.02. 00291302 12030740 (Pubitemid 34567914)
16. A Prieto E Reyes ED Bernstein 2001 Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (Inmunoferón) Am J Repir Crit Care Med 163 1578 1583 1:STN:280:DC%2BD3MvgsVSqtg%3D%3D
17. A Noguera S Batle C Miralles, et al. 2001 Enhanced neutrophil response in chronic obstructive pulmonary disease Thorax 56 432 437 1:STN:280: DC%2BD3M3ns1Clsg%3D%3D 10.1136/thorax.56.6.432 11359957 (Pubitemid 32521359)
18. C Yamamoto T Yoneda M Yoshikawa, et al. 1997 Airway inflammation in COPD assessed by sputum levels of interleukin-8 Chest 112 505 510 1:STN:280:DyaK2svhtVWktA%3D%3D 10.1378/chest.112.2.505 9266891 (Pubitemid 27349446)
19. S Sethi J Maloney L Grove, et al. 2006 Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease Am J Respir Crit Care Med 173 991 998 10.1164/rccm.200509-1525OC 16474030
20. PJ Barnes 2009 The cytokine network in chronic obstructive pulmonary disease Am J Respir Cell Mol Biol 41 631 638 1:CAS:528:DC%2BD1MXhsFWisbvE 10.1165/rcmb.2009-0220TR 19717810
21. 1 decline in patients with chronic obstructive pulmonary disease Am J Repir Crit Care Med 167 1090 1095 10.1164/rccm.200210-1179OC (Pubitemid 36459654)
22. RA Stockley C O'Brien A Pye, et al. 2000 Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD Chest 117 1638 1645 1:STN:280:DC%2BD3czhs12msA%3D%3D 10.1378/chest.117.6.1638 10858396
23. S Fuke T Betsuyaku Y Nasuhara, et al. 2004 Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease Am J Respir Cell Mol Biol 31 405 412 1:CAS:528:DC%2BD2cXot12nt7k%3D 10.1165/rcmb.2004-0131OC 15220136 (Pubitemid 39330950)
24. A Bhowmik TAR Seemungal RJ Sapsford, et al. 2000 Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations Thorax 55 114 120 1:STN:280:DC%2BD3c7gslaltg%3D%3D 10.1136/thorax.55.2.114 10639527 (Pubitemid 30245950)
25. S Gompertz DL Bayley SL Hill, et al. 2001 Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD Thorax 56 36 41 1:STN:280:DC%2BD3M7isVGrsw%3D%3D 10.1136/thorax.56.1.36 11120902 (Pubitemid 32041717)
26. M Tumkaya S Atis C Ozge, et al. 2007 Relationship between airway colonization, inflammation and exacerbation frequency in COPD Respir Med 101 729 737 10.1016/j.rmed.2006.08.020 17002892